Cargando…
A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment
Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312002/ https://www.ncbi.nlm.nih.gov/pubmed/28093504 http://dx.doi.org/10.1242/dmm.025593 |
_version_ | 1782508129300250624 |
---|---|
author | Podell, Brendan K. Ackart, David F. Richardson, Michael A. DiLisio, James E. Pulford, Bruce Basaraba, Randall J. |
author_facet | Podell, Brendan K. Ackart, David F. Richardson, Michael A. DiLisio, James E. Pulford, Bruce Basaraba, Randall J. |
author_sort | Podell, Brendan K. |
collection | PubMed |
description | Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-induced glucose intolerance precedes β-cell cytotoxicity, two processes that are crucial to the development of human type 2 diabetes. Guinea pigs developed impaired glucose tolerance after 8 weeks of feeding on a high-fat, high-carbohydrate diet, as determined by oral glucose challenge. Diet-induced glucose intolerance was accompanied by β-cell hyperplasia, compensatory hyperinsulinemia, and dyslipidemia with hepatocellular steatosis. Streptozotocin (STZ) treatment alone was ineffective at inducing diabetic hyperglycemia in guinea pigs, which failed to develop sustained glucose intolerance or fasting hyperglycemia and returned to euglycemia within 21 days after treatment. However, when high-fat, high-carbohydrate diet-fed guinea pigs were treated with STZ, glucose intolerance and fasting hyperglycemia persisted beyond 21 days post-STZ treatment. Guinea pigs with diet-induced glucose intolerance subsequently treated with STZ demonstrated an insulin-secretory capacity consistent with insulin-independent diabetes. This insulin-independent state was confirmed by response to oral antihyperglycemic drugs, metformin and glipizide, which resolved glucose intolerance and extended survival compared with guinea pigs with uncontrolled diabetes. In this study, we have developed a model of sequential glucose intolerance and β-cell loss, through high-fat, high-carbohydrate diet and extensive optimization of STZ treatment in the guinea pig, which closely resembles human type 2 diabetes. This model will prove useful in the study of insulin-independent diabetes pathogenesis with or without comorbidities, where the guinea pig serves as a relevant model species. |
format | Online Article Text |
id | pubmed-5312002 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | The Company of Biologists Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-53120022017-03-06 A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment Podell, Brendan K. Ackart, David F. Richardson, Michael A. DiLisio, James E. Pulford, Bruce Basaraba, Randall J. Dis Model Mech Research Article Type 2 diabetes is a leading cause of morbidity and mortality among noncommunicable diseases, and additional animal models that more closely replicate the pathogenesis of human type 2 diabetes are needed. The goal of this study was to develop a model of type 2 diabetes in guinea pigs, in which diet-induced glucose intolerance precedes β-cell cytotoxicity, two processes that are crucial to the development of human type 2 diabetes. Guinea pigs developed impaired glucose tolerance after 8 weeks of feeding on a high-fat, high-carbohydrate diet, as determined by oral glucose challenge. Diet-induced glucose intolerance was accompanied by β-cell hyperplasia, compensatory hyperinsulinemia, and dyslipidemia with hepatocellular steatosis. Streptozotocin (STZ) treatment alone was ineffective at inducing diabetic hyperglycemia in guinea pigs, which failed to develop sustained glucose intolerance or fasting hyperglycemia and returned to euglycemia within 21 days after treatment. However, when high-fat, high-carbohydrate diet-fed guinea pigs were treated with STZ, glucose intolerance and fasting hyperglycemia persisted beyond 21 days post-STZ treatment. Guinea pigs with diet-induced glucose intolerance subsequently treated with STZ demonstrated an insulin-secretory capacity consistent with insulin-independent diabetes. This insulin-independent state was confirmed by response to oral antihyperglycemic drugs, metformin and glipizide, which resolved glucose intolerance and extended survival compared with guinea pigs with uncontrolled diabetes. In this study, we have developed a model of sequential glucose intolerance and β-cell loss, through high-fat, high-carbohydrate diet and extensive optimization of STZ treatment in the guinea pig, which closely resembles human type 2 diabetes. This model will prove useful in the study of insulin-independent diabetes pathogenesis with or without comorbidities, where the guinea pig serves as a relevant model species. The Company of Biologists Ltd 2017-02-01 /pmc/articles/PMC5312002/ /pubmed/28093504 http://dx.doi.org/10.1242/dmm.025593 Text en © 2017. Published by The Company of Biologists Ltd http://creativecommons.org/licenses/by/3.0This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution and reproduction in any medium provided that the original work is properly attributed. |
spellingShingle | Research Article Podell, Brendan K. Ackart, David F. Richardson, Michael A. DiLisio, James E. Pulford, Bruce Basaraba, Randall J. A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title | A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title_full | A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title_fullStr | A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title_full_unstemmed | A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title_short | A model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
title_sort | model of type 2 diabetes in the guinea pig using sequential diet-induced glucose intolerance and streptozotocin treatment |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5312002/ https://www.ncbi.nlm.nih.gov/pubmed/28093504 http://dx.doi.org/10.1242/dmm.025593 |
work_keys_str_mv | AT podellbrendank amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT ackartdavidf amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT richardsonmichaela amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT dilisiojamese amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT pulfordbruce amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT basarabarandallj amodeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT podellbrendank modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT ackartdavidf modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT richardsonmichaela modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT dilisiojamese modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT pulfordbruce modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment AT basarabarandallj modeloftype2diabetesintheguineapigusingsequentialdietinducedglucoseintoleranceandstreptozotocintreatment |